| 
Grant
happy : Hearts, minds - even urban neighborhoods - will
gain from $113 million in Third Frontier money flowing
to NE Ohio
A little over a year ago, voters approved pouring $500
million of state money into high-tech projects, betting
it would create jobs here and keep - and lure - coveted
scientists and promising start-up companies.
$60
Million in State Funding to Develop Global Cardiovascular
Innovation Center
Cleveland Clinic, in collaboration Fairfax Renaissance
Development Corporation (FRDC) and more than 20 biomedical
and academic institutions, will receive $60 million
from the State of Ohio to develop a Global Cardiovascular
Innovation Center (GCIC).
State
money for technology, jobs NE Ohio gets a high-tech
boost State grants to create jobs here Third Frontier
cash to add jobs: Clinic-led effort is one of 6 in region
sharing $113 million $113 million in Third Frontier
cash to go to six projects The state will pour more than $113 million
in Third Frontier money into Northeast Ohio, including
$60 million for a Cleveland Clinic-led effort that could
create hundreds of jobs and establish the city as a
hub of biotech innovation.
Scientists
harness mysteries of the brain
A young woman, confined to a wheelchair, is told to
think about moving another wheelchair in front of her,
first to the left and then forward.
Neurotechnology
development treads tougher VC funding path
As the Cleveland Clinic Innovation Summit
began to wind down last week, the promise of the neuroscience
field was tempered with the realization that someone
has to pay to develop all of these future and very enticing
technologies.
Cleveland
Clinic Unveils Top 10 Medical Innovations for '07
Last week, Cleveland Clinic announced its
first-ever Top 10 Medical Innovations list, highlighting
technologies that will likely have a big impact on healthcare
in 2007.
Clinic
unveils 'Top Ten' list of medical innovations for 2007As an interesting addition this year
to its Innovation Summit, the Cleveland Clinic unveiled
the first of what promises to be an annual “Top
Ten” list of what it predicts as the most promising
medical innovations in the coming year.
Real
surgeries, amazing results
"This is really neat stuff you're about
to see," Cleveland Clinic Wooster gastroenterologist
James Murphy told a group of students privileged to
observe live surgeries performed by internationally
recognized Cleveland Clinic surgeons.
As
in cardiology, implantable' is wave of neuromodulation
future
Within the promising early-stage realm of neuroscience,
one area of particular interest for physicians, patients
and investors is undoubtedly implantable neuromodulation
devices.
Cleve
BioLabs in defense contract talks
Cleveland BioLabs Inc., a drug discovery and development
company, has begun contract negotiations with the Defense
Threat Reduction Agency to complete development of radiation
protectors for the U.S. Department of Defense.
Clinic
targets changing medicine via new Neurological Institute
As the Cleveland Clinic Innovation Summit got underway
this week, this top-tier medical and research facility
wasted no time in getting to the topic that was to be
a primary one at this fourth annual event — the
field of neuroscience.
Cooperation
a must to restrain health costs
The government and public and private entities will
need to work together to reduce skyrocketing health
care costs and the number of uninsured Americans.
Ten
emerging technologies will shape healthcare next year,
hospital predicts
Cleveland Clinic today announced its first-ever Top
10 Medical Innovations list, highlighting technologies
which will likely have a big impact on healthcare in
2007.
Cancer
vaccines top innovation list at Clinic
Cancer vaccines will have the biggest impact on health
care in 2007, a panel of Cleveland Clinic physicians
and scientists predicts.
Meeting
set to spotlight the embryonic neurology field
According to Chris Coburn, executive director of CCF
Innovations— the technology transfer and commercialization
arm of the Cleveland Clinic— this year’s
Innovation Summit, which is focusing on the neurology
market, was not as easy a sell as the past three conferences
have been.
Conference
blends business, medicine
The Cleveland Clinic is convening more than 800 medical
and business professionals on its campus today to talk
about developing, investing in and paying for medical
devices and therapies related to the brain.
Implant
gives brain-injured patient, researchers hope A constant trickle of electricity into the
severely damaged and semiconscious brain of a 38-year-old
assault victim has made him significantly more aware
and responsive, a Cleveland Clinic neurosurgeon and
his colleagues reported Sunday.
State
doesn't keep the right graduates: Science PhDs tend
to go elsewhere
The human heart sparks electricity with each beat. When
it skips and its rhythm breaks, life turns fragile.
Clinic,
Case, KSU vie for pot of tech grant money
The Cleveland Clinic, Case Western Reserve University
and Kent State University all are competing for a lucrative
but limited supply of dollars from the state’s
Third Frontier technology development program.
BioLabs
gets $750k for research
Cleveland BioLabs Inc. has received a $750,000 small
business research grant from the National Institutes
of Health to advance research into substances that protect
healthy cells against exposure to radiation.
BioLabs
completes trial
Cleveland BioLabs Inc. (Nasdaq: CBLI) has announced
the results of clinical trials of a radioprotective
drug on monkeys — something it said it hopes will
help to secure U.S. Food and Drug Administration approval
of a drug that protect humans against radiation.
Cleveland
BioLabs takes leap into choppy waters for IPOs
If recent months are any indication, the stock of Cleveland
Clinic spinoff Cleveland BioLabs Inc. could be in for
a bumpy ride after going public last week.
Cleveland
Clinic spinoff goes public: BioLabs will use money for
drug development
Cleveland BioLabs Inc., a spinoff of the Cleveland Clinic
that is working on anti-radiation and cancer drugs,
went public Thursday. The company expects to net $8.5
million from its public offering of 1.7 million shares.
Clinic
licenses stem cell therapies
The Cleveland Clinic and its technology transfer unit,
CCF Innovations, have licensed five pending patents
on stem cell therapies for repairing scarred hearts
to Bioheart Inc. of Sunrise, Fla.
Cleve.
Biolabs plans $14M IPO
Cleveland Biolabs Inc., a development-stage biodefense
and cancer treatment pharmaceutical products company,
hopes to raise nearly $14 million in a public stock
offering. |
